U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975917) titled 'Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers (TOG/GI-SAFRADJU-2501)' on April 30.
Brief Summary: The goal of this observational study is to compare chemotherapy types that are given after surgery for biliary tract cancers. The main question it aims to answer is:
Are any of the chemotherapy regimens more effective in preventing recurrence, providing longer survival, or having less toxicity?
Nationwide multicenter retrospective data will be collected.
Study Start Date: Nov. 01, 2024
Study Type: OBSERVATIONAL
Condition:
Biliary Tract Cancer
Biliary Tract Cancers (BTC)
Intervention:
DRUG: Chemotherapy
Any che...